3) 中高年女性の健康管理プログラム策定における基礎的・臨床的検討(シンポジウム1:女性ヘルスケア「中高年に対する女性医学の展開」,第64回日本産科婦人科学会・学術講演会)
スポンサーリンク
概要
- 論文の詳細を見る
Objectives It is supposed that many disorders increased in middle-aged women are resulting from the dysfunction of the organ accompanying aging changes and the chronic decrease or lack of estrogens due to the menopause. These disorders are sometimes detected in especially only a single organ but also overlapped organs by changing component of extracellular matrix as collagens, proteoglycans and hyaluronic acids distributed in the whole body. In any case, dysfunctions of organs have considerable influence on middle-aged women's quality of life (QOL). Then it might be very important that when and how we perform medical intervention for the prevention or treatment of organ dysfunctions or diseases. The aim of this report is to grasp middle-aged women's health condition comprehensively and consider how to predict these organ dysfunctions effectively using epidemiological, clinical and basic data. Materials and Methods The data from the cohort study were mainly used in this report. This cohort study named Iwaki Project is longitudinal observational study of residents in the rural area of Hirosaki city and has been performed annually since 2005. This cohort study is investigating several factors concerning about the health condition of residents gathering the participants at same place once a year. About 1,100 persons participate every year and about 700 persons are women (including about 400 perimenopausal or postmenopausal women), and a repetitive participating rate is high. In this report, we also used other data which were obtained from women in the outpatient clinic of our hospital or co-researchers institution and from rats in basic research. These data were analyzed following researches as below. 1) Frequency of morbidity of the life-style related diseases in the local residents: We analyzed morbidity of these diseases including the osteoporosis horizontally in 240 postmenopausal women at Iwaki project and the relation among each disease was investigated. 2) The new predictive marker of osteoporosis: Clinically we investigated the relation between plasma homocysteine or urine pentosidine and the future fractures of the 251 osteoporotic women at the hospital or the clinic. Basically using osteoporotic animals (OVX rats), we compared the changes of some components, for example, proteoglycan (PG) or its functional sugar chain (glycosaminoglycan, GAG) in the extracellular matrix of the femur bone tissue with control (both groups were consisted of ten Wistar female rats respectively) and otherwise using human urine we also compared urine GAG between healthy and osteoporotic postmenopausal women (ten cases each). 3) The common factor between osteoporosis and dyslipidemia: It is supposed that the common factor in the relationship of bone-fat-vascular disorders may be some cytokines including adipocytokines or some aging markers like a pentosidine. To observe relationship between bone mineral density (BMD) using osteo-sono index and data of lipoprofiles, cytokines and aging markers within an annual interval in 99 postmenopausal women participated in Iwaki project at least twice. 4) The relationship between the past information at her pregnant and the present state about lifestyle related diseases using their maternity record books: We collected the 148 maternity record books from the residents participated in Iwaki Project at 2011 and observed the relationship between the data from each maternity record book at her younger age giving the birth and the present morbidity of life-style related diseases at her middle-aged phase. The data from maternity record books as described below; weight, urine findings, blood pressures in their course at pregnant were analyzed in relation to middle-aged women's health condition of postmenopausal group. 5) More exact prediction of the menopause: We examined the possibility of the anti-mullerian hormone (AMH), which is already has used to assess the ability of ovarial reservation in the field of reproductive medicines, as more predictive factor of the menopause. Pursuing the inhibin B, follicular stimulating hormone (FSH) and 17beta-estradiol (E2) were also measured besides AMH from same cases for several years in the 256 healthy women participated repeatedly in Iwaki Project and the relationships of each data with onset of the menopause or irregular cycle of menstruation were compared respectively. Results 1) In 240 postmenopausal women who have at least one of lifestyle-related diseases such as hypertension, dyslipidemia, diabetes mellitus and osteoporosis at the time participated in this project, there were detected 27% of women who have more than two kinds of these diseases. This trend is also observed in the Japan Nurses' Health Study (JNHS) which is nationwide cohort study of women performed by The Japan Society for Menopause and Women's Health. 2) Observation of 251 osteoporotic women treated with bisphosphonates for several years showed that the high level of plasma homocysteine and urine pentosidine at baseline were related significantly with the new fracture in future. In basic research, it showed that PGs in the femur bone of the OVX rats decreased hugely more than hyaluronic acids or acid soluble collagens in same tissues. And clinically in the human urine, it showed that the GAGs, which are functional domains of PGs, in postmenopausal osteoporotic women increased more than the healthy postmenopausal women. We analyzed urine extracts from both by electrophoresis and detected the different type of GAGs (for example, chondroitin sulfate) in these urines between the osteoporotic and healthy women. There may be the possibility that osteoporotic change is started as the quantity and quality in the bone firstly, but the findings is a preliminary and further studies will be required. 3) In the analysis which pursued 99 postmenopausal women, bone mineral density would significantly decreased in the group with higher total cholesterol (TC) at one year before and also in the group with higher LDL cholesterol as a tendency. At the viewpoint of cytokines, there were detected high level of IL-8, one of inflammatory cytokine, in both groups of high TC and low BMD. 4) From analysis of the data from 148 maternity record books, it indicated that the average of the systolic arterial blood pressure above 120mmHg or diastolic blood pressure 70mmHg during pregnancy significantly increased the odds ratio for the risk of hypertension to 2.69 significantly. 5) In the 256 women observed for several years, it detected that measured values of AMH would be lower level or under sensitivity from 3 years before menstruation turned into irregularity and 4 years before onset of menopause during the observation period. Conclusion It was confirmed that the life-style related diseases in middle-aged women was often overlapped or related to each other. Beyond that, in this report, we detected high values of homocysteine or pentosidine related to new bone fracture and showed the possibility that the PGs in the bone might be a new biomarker for bone fragility. Among life-style related diseases, there was relationships between the abnormal state of lipoprofiles and the subsequent fragility of bone and the common predictive factor may be IL-8. It was also suggested that over some levels of the average blood pressure at pregnant were raised the risk of hypertension at middle-aged women. Then for the healthcare of middle-aged women, it might be important to take those predictive factors described as above into consideration at medical intervention or prevention for these diseases. Moreover, using AMH as a prediction of menopause, middle-aged women may take the opportunity watching their health around perimenopose and beyond. From the viewpoint of preventive medicine, it needs to preparing health care program of middleaged women based on more useful predictive factors. Although several factors we showed in this report including AMH may play a valuable role for prevention of life-style related diseases, further researches and verification will be required.
- 2012-10-01
著者
関連論文
- P3-21 加味逍遥散投与,ホルモン補充療法の更年期障害に対する効果の比較 : 精神神経症状評価スケール,症状推移からみた比較(訂正版)
- W5 更年期の精神神経症状に対する加味逍遙散投与,ホルモン補充療法の効果の比較(ワークショップ1「更年期医療および婦人科疾患」,これからの女性心身医学におけるサイエンスとその展望:分子レベルから臨床医学まで,第39回日本女性心身医学会学術集会)
- P3-21 加味逍遥散投与,ホルモン補充療法の更年期障害に対する効果の比較 : 精神神経症状評価スケール,症状推移からみた比較(Group100 更年期・老年期3,一般演題,第62回日本産科婦人科学会学術講演会)
- P1-265 婦人科悪性腫瘍手術術後の骨盤後腹膜処理 : 合成吸収性癒着防止剤は術後合併症を軽減できるか(Group32 婦人科腫瘍その他2,一般演題,第62回日本産科婦人科学会学術講演会)
- 更年期障害のHRTと漢方 (特集 女性にやさしい漢方療法)
- P1-27 子宮体癌手術における傍大動脈リンパ節郭清は省略可能か?(Group4 子宮体部悪性腫瘍2,一般演題,第61回日本産科婦人科学会学術講演会)
- P3-93 婦人科領域におけるPET/CT検査の臨床的意義(Group88 画像診断,一般演題,第61回日本産科婦人科学会学術講演会)
- P2-99 黄色肉芽腫性卵管炎の1例(Group45 その他良性腫瘍,一般演題,第61回日本産科婦人科学会学術講演会)
- P4-257 子宮腟部発症のWegener肉芽腫の一例(Group123 その他の良性・悪性腫瘍5,一般演題,第60回日本産科婦人科学会学術講演会)
- 超音波断層法による卵巣癌のスクリーニング (特集 増えている卵巣癌の対策)
- 242 性交が分泌期中期子宮内膜組織中の免疫細胞に与える影響
- 体外受精・胚移植における多胎妊娠の発生に影響する因子の検討
- 111 精子授精能検査の検討 : Hamster testとCa ionophore A23187 challenge testの相関について
- P3-144 ホルモン補充療法,加味逍遥散投与の更年期障害に対する効果の比較(Group83 生殖生理・病理2,一般演題,第60回日本産科婦人科学会学術講演会)
- P3-99 一般女性における内臓脂肪とメタボリックシンドロームに対する検討(Group78 更年期・老年期3,一般演題,第60回日本産科婦人科学会学術講演会)
- P3-96 一般女性における脂質系と音響的骨評価値の相関に対する検討(Group78 更年期・老年期3,一般演題,第60回日本産科婦人科学会学術講演会)
- P-198 子宮頸管熟化抑制の基礎的研究
- 出生前診断した先天性無眼球症の1例
- P2-31 隔年検診施行後の子宮がん検診の現状(Group38 子宮頸部悪性腫瘍8,一般演題,第60回日本産科婦人科学会学術講演会)
- 当教室[弘前大学医学部産科婦人科学教室]におけるホルモン療法の実際 (特集 女性のヘルスケアとホルモン療法--女性のQOL向上を目指して)
- P3-339 炎症性サイトカインとメタボリックシンドローム診断基準項目との相関(Group118 女性医学基礎,一般演題,第61回日本産科婦人科学会学術講演会)
- P-242 子宮内腔液性成分の単糖組成に関する検討
- 卵胞内精子注入法の有用性に関する検討
- 196 ヒト子宮頚管由来培養線維芽細胞におけるヒアルロン酸代謝に及ぼすホルモンの影響
- 382 ヒト子宮頸管培養線維芽細胞におけるヒアルロン酸の合成と分解の調節
- 494 ヒト子宮頸管由来培養線維芽細胞のglycosaminoglycan産生とその産生のkey enzyme活性に及ぼす各種ステロイドホルモンの影響について
- P3-341 脂質異常症による骨密度低下に関するサイトカインやホモシステインの存在(Group118 女性医学基礎,一般演題,第61回日本産科婦人科学会学術講演会)
- 一般女性におけるサイトカインと音響的骨評価値の相関に関する検討 (第19回婦人科骨粗鬆症研究会)
- 当科における中高年女性の健康管理 (特集 中高年女性のヘルスケア--最近の話題)
- 主な骨粗鬆症治療薬の特徴,有用性,長期使用による有害事象 エストロゲン製剤 (特集 骨粗鬆症の薬物療法--薬効評価と臨床研究の進歩) -- (薬物療法各論)
- WHI報告後におけるホルモン補充療法の現状と課題 (特集 知っておきたい今日のホルモン療法)
- P-123 子宮内膜NK細胞サブポピュレーションに関わるTh細胞優位性の検討
- 173 4-メチルウンベリフェロンによる線維芽細胞のヒアルロン酸合成阻害とプロテオグリカン合成促進について
- 162 ヒト子宮頚管由来培養線維芽細胞のガラクトシルトランスフェラーゼI活性化因子の性状について
- 336 高電圧パルスによる配偶子活性化の検討
- 381 ヒト子宮頸管由来培養線維芽細胞のgalactosyltransferase I 活性に及ぼす各種プロスタグランジンの影響について
- K-36 一般住民を対象とした集団検診におけるFRAXの検討(高得点演題9 女性医学,第63回日本産科婦人科学会学術講演会)
- Acinetobacter baumannii による敗血症からDICに至った重症妊娠悪阻症例
- 子宮内膜癌 (特集 ホルモン補充療法の最新知識 : リスク・ベネフィットを今,どう考えるか)
- HRTは骨粗鬆症治療薬となりうるか? (第26回女性医学学会学術集会) -- (スポンサードシンポジウム)
- 更年期症状・泌尿生殖器症状の改善 (今月の臨床 ホルモン補充療法ガイドライン2012年度版 : 改訂版を読み解く) -- (HRTに期待される作用・効果)
- 更年期障害の諸症状に対する加味逍遙散,ホルモン補充療法の効果比較 : 無作為割付研究の結果より
- 3) 中高年女性の健康管理プログラム策定における基礎的・臨床的検討(シンポジウム1:女性ヘルスケア「中高年に対する女性医学の展開」,第64回日本産科婦人科学会・学術講演会)
- 3) 中高年女性の健康管理プログラム策定における基礎的・臨床的検討(女性ヘルスケア「中高年に対する女性医学の展開」,シンポジウム1,公益社団法人日本産科婦人科学会第64回学術講演会)
- P2-22-5 妊娠時の血圧と将来の成人病発症の関連性 : 母子手帳の解析から(Group78 更年期・老年期1,一般演題)
- P2-30-6 将来の産婦人科医獲得を目指した我々の取り組み(Group86 女性医学(臨床),一般演題,第64回日本産科婦人科学会学術講演会)
- P2-22-1 閉経前後における血中AMH(抗ミューラー管ホルモン)値の推移 : 同一症例における検討(Group78 更年期・老年期1,一般演題)
- P2-48-1 閉経予測マーカーとしてのAMH,InhibinB,FSH,E2の有用性に関する検討(Group 100 更年期・老年期・閉経2,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- P2-43-7 骨盤位経腟分娩は時代遅れなのか?(Group 95 分娩手技2,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- P1-39-7 血糖コントロール不良糖尿病が原因と考えられた尾部退行症候群の一例(Group 39 合併症妊娠(症例)2,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)